Owner Novo Nordisk Health Care AG

Inventors Pingel, Hans Kurt; Klausen, Niels Kristian

Agent Shelston IP

Pub. Number AU-A-2007214306

Parent 2001291652

Filing date 30 August 2007

Wipo publication date 20 September 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms